Related Experiment Video
Updated: Jun 5, 2026

07:07
A Melanoma Patient-Derived Xenograft Model
Published on: May 20, 2019
Neoadjuvant PD-1 Blockade in Surgically Resectable Desmoplastic Melanoma: Cohort A of the Phase 2 SWOG S1512 Trial
Edmund K Bartlett1, Christopher A Barker2
1Gastric and Mixed Tumor Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. bartlete@mskcc.org.
Annals of Surgical Oncology
|June 4, 2026
Abstract
No abstract available in PubMed .
